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2Abstract
ATM (ataxia-telangiectasia mutated) is activated by a variety of noxious agent, including
oxidative stress, and ATM deficiency results in an anomalous cellular response to oxidative stress.
However, the mechanisms for ATM activation by oxidative stress remain to be established.
Furthermore, it is not clear whether ATM responds to oxidative DNA damage or to a change in
the intracellular redox state, independent of DNA damage. We found that ATM is activated by
N-methyl-N'-nitro-nitrosoguanidine (MNNG) and 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2),
in NBS1- or MSH6- deficient cells. We further found that ATM is activated by treating
chromatin-free immunoprecipitated ATM with MNNG or 15d-PGJ2, which modifies free
sulfhydryl (SH) groups, and that 15d-PGJ2 binds covalently to ATM. Interestingly, 15d-PGJ2-
induced ATM activation leads to p53 activation and apoptosis, but not to Chk2 or H2AX
phosphorylation. These results indicate that ATM is activated through the direct modification of
its SH groups, independent of DNA damage, and this activation leads, downstream, to apoptosis.
     
3Introduction
Ataxia-telangiectasia (A-T) is an autosomal recessive disorder with pleiotropic clinical
phenotypes, including progressive cerebellar ataxia, oculocutaneous telangiectasias, immune
deficiencies, premature aging, gonadal dysgenesis, growth retardation, and a high incidence of
lymphoid malignancies. Cells derived from A-T patients are characterized by genomic instability and
extreme sensitivity to ionizing radiation (IR). In response to IR, they fail to arrest during DNA
synthesis or to stop at the G1/S or G2/M cell-cycle checkpoints, suggesting these cellular anomalies
are a major underlying cause of the disease. The 350-KDa product of the gene mutated in A-T
(designated ATM) is closely related to the yeast checkpoint proteins Rad3 and Mec1. These proteins
form a family of large protein kinases characterized by a carboxy-terminal phosphatidylinositol (PI)-3
kinase-like domain, and play essential roles in DNA repair and cell-cycle checkpoint control by
phosphorylating key downstream molecules. Many recent studies have established that vertebrate
ATM acts on a number of effector proteins following IR, notably p53, Chk2, and c-Abl, which is
consistent with ATM being a major regulator of the cellular response to IR-generated DNA damage
(Shiloh and Kastan, 2001). In addition, ATM is involved in homologous recombinational DNA repair,
an essential DNA repair system for double-strand breaks (DSB) in the DNA of vertebrate cells
(Morrison et al., 2000). ATM is thus specifically involved in cellular responses to DSB DNA damage
in vertebrate cells. On the other hand, ATR (ATM-Rad3 related), another vertebrate family member
that is even more closely related to Rad3/Mec1, plays an essential role in checkpoint responses to
hydroxyurea, UV, cisplatin, 4-nitroquinolin, or other agents, which do not induce DSB directly, but
rather cause DNA replication to stall (Abraham, 2001).
The results of several recent studies indicate that ATM is activated by a variety of noxious
agents, such as alkylating agents, oxidative stress, poly-Q aggregates, and UVA (Adamson et al., 2002;
Giuliano et al., 2003; Shackelford et al., 2001; Zhang et al., 2002), which may not directly generate
DSB. Furthermore, it is now clear that the loss of ATM results in an anomalous cellular response to
oxidative stress. This includes decreased levels of catalase activity, increased levels of lipid
4hydroperoxides, reduced levels of cyclic nucleotides such as NADH and NADPH, enhanced
generation of reactive oxygen species, enhanced heme oxygenase mRNA expression, and increased
levels of oxidant-modified proteins and lipids in ATM-deficient cells lines or tissues, including the
brain of ATM knockout mice (Barlow et al., 1999; Kamsler et al., 2001; Stern et al., 2002; Takao et al.,
2000). More recently, impaired self-renewal of hematopoietic stem cells in ATM knockout mice has
been attributed to the defective response to oxidative stress (Ito et al., 2004). Thus, the defective
response to oxidative stress may underlie the pathogenesis of some of the clinical phenotypes of A-T,
such as cerebellar ataxia, premature aging, growth retardation, and cancer predisposition. Nonetheless,
it remains to be established how ATM is activated by oxidative stress or other noxious agents that may
not directly induce DSB. Furthermore, the molecular mechanisms underlying the apoptosis of
postmitotic cerebellar Purkinje cells, which is responsible for cerebellar ataxia, have remained elusive.
A reactive cyclopentenone-type prostaglandin (15-deoxy-D12,14-prostaglandin J2, 15d-PGJ2) is
a prostaglandin D2 metabolite generated during inflammatory processes that is, due to the presence of
a reactive a,b-unsaturated ketone in the cyclopentenone ring, a potent inducer of intracellular
oxidative stress (Gilroy et al., 1999; Kondo et al., 2001; Shibata et al., 2002).  Furthermore, 15d-PGJ2
has been shown to directly modulate the activity of several biologically important molecules, such as
NF-kB, IkB kinase, H-Ras, and thioredoxin, through the specific alkylation of free sulfhydryl (SH)
groups on cysteine residues of the target proteins (Cernuda-Morollon et al., 2001; Oliva et al., 2003;
Rossi et al., 2000; Shibata et al., 2003). An alkylating agent, N-methyl-N'-nitro-nitrosoguanidine
(MNNG), is another potential oxidative stress inducer (Reitman et al., 1988) that reacts with free SH
groups (Johnson and Greenberg, 1973; Nagao et al., 1971; Sugimura et al., 1968), although MNNG is
well known to methylate DNA (e.g., O6-methylguanine (O6-MeG)) (Stojic et al., 2004a), and
effectively induces checkpoint activation through the activation of both ATM and ATR with the
subsequent activation of Chk1 and Chk2 (Beardsley et al., 2005; Stojic et al., 2004b; Wang and Qin,
2003).
Here, we used these two agents to study whether ATM responds to the oxidative or methylation
damage of DNA or, rather, to a change in the intracellular redox state, independent of DNA damage.
5To address this issue specifically, we used NBS1- and MSH6-deficient cells that were generated by
targeted disruption. Nbs1 forms an evolutionarily conserved complex with Mre11 and Rad50, in which
Nbs1 interacts with ATM and recruits it to DSB sites. Nbs1 is essential for DSB-induced ATM
activation and the subsequent phosphorylation of ATM target proteins, such as Nbs1 itself, Chk2, and
SMC1, in vertebrate cells (Falck et al., 2005; Kitagawa et al., 2004; Lee and Paull, 2004; Lee and
Paull, 2005; Uziel et al., 2003). Msh6 and Msh2 form an evolutionarily conserved mismatch repair
complex (MutSa). They recognize methylated DNAs such as O6-MeG (Stojic et al., 2004a) and are
required for MNNG-induced ATR activation and Chk1 phosphorylation by ATR (Stojic et al., 2004b;
Wang and Qin, 2003). In the present study, we found that ATM is activated by MNNG and 15d-PGJ2
in an Nbs1- and Msh6-independent manner. We further found that ATM is activated by the direct
treatment of chromatin-free immunoprecipitated ATM with MNNG or 15d-PGJ2, through the
modification of SH groups on ATM, and that 15d-PGJ2 covalently binds to ATM. Interestingly, 15d-
PGJ2-induced ATM activation leads to the phosphorylation and accumulation of p53 and to apoptosis,
but not to Chk2 or H2AX phosphorylation in human tumor cells. These results indicate that ATM is
directly activated by free SH-group-modifying agents and thereafter induces a distinct downstream
response.
Results
     
MNNG activates ATM in an Nbs1- and Msh6-independent manner. To study the mechanisms
by which MNNG activates the ATM kinase, we developed an IP kinase assay for ATM in chicken
DT40 cells, using anti-chicken ATM antibodies. The rational for using DT40 cells was the availability
of a panel of stable isogenic knockout cell lines, including ATM-/-, NBS1-/-/-, RAD17-/-, RAD9-/-, and
MSH6-/- lines (Kobayashi et al., 2004; Takao et al., 1999; Tauchi et al., 2002)(Supplementary Fig. 1).
However, since the human ATM autophosphorylation site (Ser-1981) (Bakkenist and Kastan, 2003) is
not conserved in chicken ATM (Supplementary Fig. 2), and since some agents such as okadaic acid
(OA) induce ATM autophosphorylation on Ser-1981 but not ATM kinase activation (Goodarzi et al.,
62004), we adopted the IP ATM kinase assay to measure ATM activation. In this kinase assay, a GST-
chicken Rad9 fusion protein rather than a PHAS-1 artificial substrate was used as the substrate for the
chicken ATM kinase, because a region containing an ATM phosphorylation site corresponding to Ser-
272 in human Rad9 (Chen et al., 2001) is well conserved in chicken Rad9 (Kobayashi et al., 2004)
(Supplementary Fig. 3) and because this fusion protein gives more reliable results than PHAS-1, with
low background.  Using this ATM IP kinase assay, we confirmed that Nbs1 is required for effective
IR-induced ATM activation (Supplementary Fig. 4) (Falck et al., 2005; Kitagawa et al., 2004; Uziel et
al., 2003). Having established the ATM kinase assay in DT40 cells, we then analyzed the activation of
ATM kinase in wild-type DT40 cells treated with various concentrations of MNNG. As shown in Fig.
1A, the ATM kinase was effectively activated with MNNG; the maximum activation of ATM was
observed with 200 mM MNNG for 1 hr, though 10 mM MNNG was sufficient to kill 99% DT40 cells
(data not shown). However, higher concentrations of MNNG were rather inhibitory for ATM kinase
activity, as we found that excess SH modification of ATM is inhibitory (see also Fig.2).
If some DNA lesions caused by MNNG, such as O6-MeG, generate DSB through DNA repair or
replication and then activate ATM, NBS1-deficient cells should show an impaired ATM response to
MNNG. To test this hypothesis, we treated NBS1-/-/- cells with MNNG and examined ATM activation
and the phosphorylation of Chk1 (Ser-345) and Chk2 (Thr-68). A recent study showed that Nbs1, in
addition to its role in DSB-induced ATM activation, is involved in the ATR-mediated Chk1
phosphorylation induced by HU and UV (Stiff et al., 2005). Consistent with these findings, the
MNNG-induced Chk1 phosphorylation on Ser-345 was severely diminished in NBS1-/-/- cells (Fig. 1B).
In the wild-type cells, we also observed MNNG-induced Chk2 phosphorylation (Fig. 1B), which was
previously shown to be independent of human ATM and of Mlh1 mismatch repair proteins,
particularly at higher MNNG concentrations (Beardsley et al., 2005), such as those used in the present
study (see also Fig. 1D and Fig. 5B). However, as shown in Fig. 1B, we observed greatly reduced
MNNG-induced Chk2 phosphorylation in NBS1-/-/- cells, indicating that ATM and mismatch repair
proteins are dispensable, but Nbs1 is required for the Chk2 phosphorylation induced by high
concentrations of MNNG. Fig. 1C shows that, despite the requirement for Nbs1 for MNNG-induced
7Chk1 and Chk2 phosphorylation, MNNG effectively induced ATM kinase activation in NBS1-/-/- cells,
the degree of which was comparable to the level observed in wild-type cells. These results indicate
that, in contrast to the MNNG-induced phosphorylation of Chk1 and Chk2, which is dependent on
Nbs1, MNNG-induced ATM kinase activation is independent of Nbs1.
MutSa, which consists of Msh2 and Msh6, is known to bind the O6-MeG generated by MNNG
and is involved in the ATR-mediated Chk1 phosphorylation induced by MNNG (Stojic et al., 2004b),
through direct interactions with ATR (Wang and Qin, 2003). As shown in Fig. 1D, we confirmed the
requirement for Msh6 for MNNG-induced and ATR-mediated Chk1 phosphorylation. However, we
observed that the ATM kinase was effectively activated in MSH6-/- cells in response to MNNG (Fig.
1E), in agreement with previous findings that MNNG induces the activation of ATM kinase in human
MLH1-deficient HCT116 cells (Adamson et al., 2002). In addition, O6-benzyl guanine, a specific
inhibitor for methylguanine methyltransferase, neither inhibited nor enhanced MNNG-induced ATM
activation (data not shown).
ATM is directly activated by MNNG through the modification of free SH groups
The above results, showing that MNNG-induced ATM kinase activation requires neither Nbs1
nor Msh6 (Fig. 1), raise the possibility that MNNG acts directly on ATM, rather than through the
generation of methylated DNA. To explore this possibility, immunoprecipitated ATM, prepared from
untreated DT40 cells with antibodies specific for chicken ATM, was treated with MNNG, and the
ATM kinase activity was measured. As shown in Fig. 2A, ATM was significantly activated by MNNG
in this chromatin-free experiment, and much lower concentrations of MNNG (0.2 mM) were sufficient
for the maximum activation of ATM activity. These results further support the possibility that MNNG
acts directly on ATM rather than through the generation of methylated DNA. Since, in addition to
methylating DNA, MNNG modifies SH groups on cysteine residues in some proteins (Johnson and
Greenberg, 1973; Nagao et al., 1971; Sugimura et al., 1968), we investigated whether the MNNG-
mediated modification of ATM’s SH groups is involved in the cell-free activation of ATM by MNNG.
Immunoprecipitated ATM was therefore pre-treated with a SH-specific agent, N-ethylmaleimide
(NEM), before MNNG treatment. As shown in Fig. 2B, the activation of ATM by 0.5 mM MNNG was
8completely inhibited by the pre-treatment with excess NEM (1 mM). Furthermore, the basal activity of
ATM decreased after pre-treatment with high concentrations of NEM (4 mM), indicating that excess
SH modification is inhibitory for the ATM kinase activity. These results suggest that ATM is activated
by MNNG through the modification of critical SH groups in ATM, independent of DNA modification,
and that excess SH modification is rather inhibitory for the ATM kinase activity.
15d-PGJ2 covalently binds and activates ATM
Because SH groups seemed to be important for the direct activation of the ATM kinase by
MNNG (Fig. 2B), we studied whether another specific SH-reactive oxidative stress inducer, 15d-PGJ2,
would induce ATM kinase activation. DT40 cells were treated with various concentrations of 15d-
PGJ2 for 1 h, and the ATM kinase activity was measured. As shown in Fig. 3A, ATM was effectively
activated with 20 mM of 15d-PGJ2, and this 15d-PGJ2-induced ATM activation was observed in NBS1
-
/-/- DT40 cells (data not shown). However, ATM activation was not observed with 9,10-dihydro-15d-
PGJ2 (CAY, Fig. 3B). This 15d-PGJ2 analog, unlike 15d-PGJ2, lacks an electrophilic a,b-unsaturated
ketone, and therefore can neither function as an oxidative stress inducer nor react with the SH groups
of target proteins (Shibata et al., 2003). Interestingly, we did not detect significant Chk1, Chk2 and
H2AX phosphorylation in cells treated with 15d-PGJ2 (data not shown, see also Fig. 5A and 5C),
although MNNG effectively induced Chk1, Chk2 and H2AX phosphorylation along with ATM kinase
activation (Fig. 1 and 5). We then treated immunoprecipitated ATM, prepared from untreated cells,
with 15d-PGJ2, and measured the ATM kinase activity. The results, shown in Fig. 3C, indicate that,
similar to the MNNG treatment, the ATM kinase was also effectively activated by the direct treatment
of immunoprecipitated ATM with low concentrations of 15d-PGJ2 (0.2 nM).
Because 15d-PGJ2 directly modulates the biological activities of NF-kB, IkB kinase, H-Ras, and
thioredoxin through covalent binding to specific cysteine residues (Cernuda-Morollon et al., 2001;
Oliva et al., 2003; Rossi et al., 2000; Shibata et al., 2003), we used biotinylated 15d-PGJ2 to
investigate whether 15d-PGJ2 binds to ATM. Immunoprecipitates prepared from wild-type or ATM
-/-
DT40 cells with antibodies specific to chicken ATM were treated with 50 mM biotinylated 15d-PGJ2
and then immunoblotted with HRP-conjugated NeutrAvidin. As shown in Fig. 4A, biotinylated 15d-
9PGJ2 bound to ATM was detected in the immunoprecipitates prepared from wild-type but not ATM
-/-
DT40 cells. In addition, we analyzed 15d-PGJ2 binding to HA-tagged human ATM (HA-hATM). HA-
hATM was induced with doxycycline in ATM-/- DT40 cells stably expressing inducible HA-hATM
(ATM-/-/HA-hATM), and was immunoprecipitated with anti-HA antibodies. The immunoprecipitated
HA-hATM was then treated with biotinylated 15d-PGJ2, and the 15d-PGJ2 binding to HA-hATM was
determined by immunoblot analysis with HRP-conjugated NeutrAvidin. Similar to chicken ATM, we
detected biotinylated 15d-PGJ2 bound to HA-hATM only when the immunoprecipitates were prepared
from cells in which the HA-hATM expression was induced by doxycycline (Fig. 4B). In another
experiment, we treated ATM-/-/HA-hATM cells with biotinylated 15d-PGJ2 after HA-hATM induction.
Biotinylated 15d-PGJ2-binding proteins were then precipitated with NeutrAvidin Plus beads, and both
the precipitates (“Bound”) and the supernatants (“Unbound”) were immunoblotted with anti-HA. As
shown in Fig. 4C, while HA-hATM was found exclusively in the “Unbound” fraction in the absence of
treatment with biotinylated 15d-PGJ2, all the HA-hATM was detected in the “Bound” fraction after
treatment with biotinylated 15d-PGJ2. The results of these experiments demonstrate that 15d-PGJ2
binds to ATM, presumably through the alkylation of ATM’s cysteine residues.  
15d-PGJ2 induces p53 phosphorylation and apoptosis in an ATM-dependent manner
Since 15d-PGJ2 effectively activated the ATM kinase, it was important to investigate the possible
functional consequences of ATM activation by 15d-PGJ2. However, we could not study one of the
important ATM target molecules, p53 (Shiloh and Kastan, 2001), in DT40 cells, because p53
expression is extremely low in these cells (Takao et al., 1999), and the ATM phosphorylation site in
the N-terminal region of p53 is not conserved in chicken p53 (Soussi T, 1988). In addition, the
phosphorylation of Chk1, Chk2 and H2AX was not observed in DT40 cells in response to 15d-PGJ2
(data not shown). We therefore analyzed the phosphorylation of p53 (Ser-15) and Chk2 (Thr-68) in the
YZ5 (ATM+) and EBS (ATM-) human cell lines (Ziv et al., 1997) following treatment with 15d-PGJ2.
As shown in Fig. 5A, 15d-PGJ2 induced p53 phosphorylation in the YZ5 cells but not the EBS cells,
establishing that ATM-dependent phosphorylation of p53 is induced by 15d-PGJ2. However, the
phosphorylation of Chk2 (Fig. 5A) was not detected in either cell line, just as in the DT40 cells. On
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the other hand, IR effectively induced the phosphorylation of both Chk2 and p53 in the YZ5 cells, and
the degree of phosphorylation of both proteins was much lower in the EBS cells (Fig. 5B), confirming
the inductions of ATM-dependent p53 and Chk2 phosphorylation by IR. However, MNNG effectively
induced the phosphorylation of Chk2 and p53 in both the YZ5 and EBS cells, indicating that MNNG-
induced p53 or Chk2 phosphorylation is only partially dependent on ATM. Since we could not detect
ATM autophosphorylation on Ser-1981 in YZ5 cells following IR treatment, due to the extremely low
ATM expression in the YZ5 line, we studied ATM autophosphorylation and H2AX phosphorylation
(Ser-139) along with p53 phosphorylation in MCF7 cells. As shown in Fig. 5C, 15d-PGJ2 (40 mM)
induced only a marginal degree of ATM autophosphorylation, though 15d-PGJ2 was effective in p53
phosphorylation and accumulation. In addition, we could not detect significant H2AX phosphorylation
following the 15d-PGJ2 treatment, even though MNNG was very effective in phosphorylating H2AX
(Fig. 5C). This result is consistent with previous findings that agents that alter chromatin structure
without introducing detectable DSB induce ATM autophosphorylation but not H2AX phosphorylation
(Bakkenist and Kastan, 2003).   
Because ATM activation and p53 phosphorylation were observed in response to 15d-PGJ2, we
investigated whether 15d-PGJ2 induces ATM-dependent apoptosis in human cells. YZ5 and EBS cells
were treated with 40 mM of 15d-PGJ2 for 24 h, and apoptotic cells were quantified using annexin V
FACS analysis. The results shown in Fig. 5D indicate that 15d-PGJ2 induces ATM-dependent
apoptosis in human tumor cells.
Discussion
     
ATM is activated by DSB and is essential for the cellular response to DSB in vertebrate cells
(Shiloh and Kastan, 2001). ATM is also activated by a variety of noxious agents, such as alkylating
agents, oxidative stress, poly-Q aggregates, and UVA (Adamson et al., 2002; Giuliano et al., 2003;
Shackelford et al., 2001; Zhang et al., 2002), which may not directly generate DSB. Furthermore,
ATM deficiency results in an anomalous cellular response to oxidative stress (Barlow et al., 1999; Ito
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et al., 2004; Kamsler et al., 2001; Stern et al., 2002; Takao et al., 2000). While this defective response
to oxidative stress may underlie the pathogenesis of cerebellar ataxia, premature aging, growth
retardation, or cancer predisposition in A-T, the mechanisms for ATM activation by oxidative stress or
other noxious agents remain to be determined. Furthermore, it is not clear whether or not ATM
responds to oxidative DNA damage or to a change in the intracellular redox state, independent of
DNA damage. To address these issues, we studied ATM activation by MNNG in cells deficient for
NBS1 or MSH6. Msh6, as a subunit of MutSa, is required for the checkpoint response to methylated
DNA (Stojic et al., 2004b; Wang and Qin, 2003). The results of a recent study indicate that Nbs1, in
addition to its role in DSB-induced ATM activation, is required for the ATR-mediated Chk1
phosphorylation induced by HU or UV (Stiff et al., 2005). Consistent with the results of these studies,
we found that MNNG-induced and ATR-mediated Chk1 phosphorylation is Nbs1- and Msh6-
dependent (Fig. 1B and 1D). These findings establish that the Chk1 and Chk2 phosphorylation that is
linked to methylated DNA damage requires the DNA damage sensors, Msh6 and Nbs1, in addition to
early acting checkpoint proteins such as Rad17 and Rad9.  
In contrast, we found that ATM is activated by MNNG in an Nbs1- and Msh6-independent
manner (Fig. 1C and 1E), suggesting that, in addition to strict DNA damage-dependent ATR activation,
MNNG activates ATM by mechanisms that do not require methylated DNA damage or DSB, which
are potentially generated by damage to methylated DNA during DNA repair or replication. This result
is consistent with the previous findings that agents that alter chromatin structure without introducing
detectable DSB induce ATM autophosphorylation on Ser-1981 (Bakkenist and Kastan, 2003).
However, this hypothesis does not necessarily rule out the possibility that the damage to methylated
DNA is converted to DSB (Fig. 5C), the accumulation of which might result in abnormalities in the
cellular redox state under conditions of ATM deficiency.
The results of our experiments using cells deficient for NBS1 or MSH6 suggest that ATM is
directly activated by MNNG in the absence of DNA damage. Indeed, we found that ATM is activated
by the direct treatment of chromatin-free immunoprecipitated ATM with MNNG, through the
modification of critical SH groups (Fig. 2). However, it is possible that catalytic SH groups of ATM-
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associated phosphatase-5 or phosphatase 2A (Ali et al., 2004; Goodarzi et al., 2004) are the actual
targets of MNNG. To further explore the possible involvement of ATM’s SH groups, we studied
whether 15d-PGJ2 activates ATM. 15d-PGJ2 is a potent inducer of intracellular oxidative stress (Kondo
et al., 2001) and directly modulates the activity of several biologically important molecules through
the specific alkylation of free SH groups on cysteine residues of target proteins (Cernuda-Morollon et
al., 2001; Oliva et al., 2003; Rossi et al., 2000; Shibata et al., 2003). We found that 15d-PGJ2
effectively activated the kinase activity of ATM in both intact cells and immunoprecipitates (Fig. 3).
Importantly, ATM activation was not induced with a 15d-PGJ2 analog, 9,10-dihydro-15d-PGJ2 (CAY,
Fig. 3B), which lacks the reactive electrophilic a,b-unsaturated ketone that is involved in oxidative
stress induction and SH-group reactivity (Shibata et al., 2003). Using biotinylated 15d-PGJ2, we
further demonstrated that 15d-PGJ2 covalently binds to ATM through the alkylation of ATM’s cysteine
residues (Fig. 4). These results indicate that ATM is a direct target for 15d-PGJ2, raising the interesting
possibility that critical SH groups on ATM function as a direct oxidative stress sensor, independent of
ATM’s role in the cellular response to DSB.
Alternatively, it is plausible that free SH groups, together with Ser-1981, are involved in
dormant dimer formation (Bakkenist and Kastan, 2003), and the modification of the SH groups and
Ser-1981 autophosphorylation results in ATM dissociation and activation. This idea is consistent with
the results of recent studies that suggest that ATM autophosphorylation is not sufficient for dimer
dissociation and subsequent ATM activation (Goodarzi et al., 2004; Lee and Paull, 2005). We also
found that, while 15d-PGJ2 effectively activates ATM kinase activity (Fig. 3) and subsequent p53
phosphorylation and accumulation (Fig. 5A and 5C), 15d-PGJ2 is not effective in ATM
autophosphorylation (Fig. 5C). However, the formal establishment of these hypotheses requires the
identification of the cysteine residues involved.
15d-PGJ2 is a prostaglandin D2 metabolite generated during inflammatory processes and is
characterized by the presence of a reactive a,b-unsaturated ketone in the cyclopentenone ring, which
functions as a potent inducer of intracellular oxidative stress (Gilroy et al., 1999; Kondo et al., 2001;
Shibata et al., 2002). The results of immunohistochemical analysis indicate that 15d-PGJ2 is detected
13
in foamy macrophages in human atherosclerotic plaques, lipopolysaaccharide-stimulated macrophages,
inflammation-induced pleural exudates, or spinal cord tissues from patients with amyotrophic lateral
sclerosis (Gilroy et al, 1999; Kondo et al, 2002; Shibata et al, 2002). Furthermore, 15d-PGJ2 directly
modulates the activity of several biologically important molecules, such as NF-kB, IkB kinase, H-Ras,
and thioredoxin, through the specific alkylation of free SH groups on cysteine residues in target
proteins (Cernuda-Morollon et al., 2001; Oliva et al., 2003; Rossi et al., 2000; Shibata et al., 2003). In
the present study, we demonstrated that ATM is another direct target of 15d-PGJ2 (Fig. 3 and 4).
However, in contrast to DSB-induced ATM activation, this 15d-PGJ2-induced ATM activation is
independent of Nbs1 and results in the phosphorylation and accumulation of p53 and in apoptosis, but
does not cause the phosphorylation of Chk2 or H2AX (Fig. 5). This pattern of ATM activation by 15d-
PGJ2 is consistent with previous findings; although p53 phosphorylation and ATM
autophosphorylation are Nbs1-independent, Chk2 phosphorylation is Nbs1-dependent and strictly
linked to DNA damage (Falck et al., 2005; Kitagawa et al., 2004); agents that alter chromatin structure
without introducing detectable DSB, induce ATM autophosphorylation but not H2AX phosphorylation
(Bakkenist and Kastan, 2003). This pattern of ATM activation by 15d-PGJ2 may be physiologically
significant, considering the anti-inflammatory and pro-apoptotic roles that 15d-PGJ2 plays in various
disease states (Castrillo et al., 2000; Kondo et al., 2002; Lee et al., 2003; Straus and Glass, 2001). In
particular, 15d-PGJ2 has been implicated in p53-dependent neuronal apoptosis (Kondo et al, 2002).
This pattern is also consistent with the observation that a portion of the extranuclear ATM localizes to
peroxisomes (Watters et al., 1999). In addition, we recently showed that 4-oxo-2-nonenal, a major
lipid peroxidation product, induces ATM autophosphorylation, p53 phosphorylation, and apoptosis in
SH-SY5Y human neuroblastoma cells (Shibata et al., 2006). ATM, therefore, may function as an early
monitor of various endogenously produced electrophilic metabolites and as a regulator of the cellular
oxidative stress response to protect cells from the toxic effects of these metabolites, or to induce
apoptosis. It is conceivable that the impairment of the ATM functions proposed here can eventually




     
Cell culture, reagents, and X-ray irradiation. DT40 cells were cultured in RPMI-1640
supplemented with 10% fetal calf serum (FCS), 1% chicken serum, 2 mM L-glutamine, 50 mg/ml
penicillin, 50 units/ml streptomycin, and 10-5 M b-mercaptoethanol at 39.5˚C in a humidified 5% CO2
incubator. The 293T, YZ5, EBS, and MCF7 cells were cultured in Dulbecco’s modified Eagle medium
(Nissui) supplemented with 15% FCS, 2 mM L-glutamine, 50 mg/ml penicillin, and 50 units/ml
streptomycin. MNNG and NEM were obtained from Nacalai tesque and SIGMA, respectively. 15d-
PGJ2 and its analog, 9,10-dihydro-15d-PGJ2 (CAY10410), were from Cayman Chemical. Biotinylated
15d-PGJ2 was prepared as previously described (Shibata et al., 2003). X-ray irradiation was performed
using an MBR-1520R radiator (Hitachi) set at 150-kVp, 20 mA, 0.5 mm aluminum, and 0.5 mm
copper filtration with a dose rate of 1 Gy/min.
Gene targeting. A chicken EST clone (AI981357) containing the amino acid sequence
homologous to human Msh6 was obtained at the NCBI web site. Oligonucleotide PCR primers were
designed based on the EST clone, and partial chicken MSH6 cDNA was amplified by RT-PCR using
RNA extracted from DT40 cells. Using the cDNA fragment as a probe, chicken MSH6 genomic clones
were isolated from a spleen lambda genomic library (Stratagene). The identity of this clone was
confirmed by DNA sequencing. MSH6 targeting vectors were constructed by replacing exons 2-4 of
the MSH6 gene with his- and bsr-selection marker gene cassettes. For gene targeting of the chicken
MSH6 locus, wild-type DT40 cells were sequentially transfected with pMSH6-his and pMSH6-bsr
(Supplementary Fig. 1), as previously described (Takao et al., 1999).
Antibodies. The 1.8-kbp DNA fragment was amplified by PCR using a partial chicken ATM
cDNA fragment (Takao et al., 1999) as a template. The PCR fragment was treated with BamHI and
KpnI, and the purified 600-bp fragment was then ligated to the BamHI- and KpnI-treated pQE31
(Qiagen), yielding His-tag-fused partial chicken ATM expression plasmids. This plasmid contains the
chicken ATM amino acid sequence corresponding to the 1943-2124 amino acids of human ATM
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(Supplementary Fig. 2). The His-tag ATM was purified with an Ni-NTA column (Qiagen) and was
used to immunize white rabbits, and anti-ATM antisera were obtained from these rabbits. Antibodies
against phospho-Chk1 (Ser-345), phospho-Chk2 (Thr-68), phospho-p53 (Ser-15), and phospho-ATM
(ser-1981) were from Cell Signaling Technology. Antibodies against phospho-H2AX (Ser-139), Chk1,
p53, ATM, and actin were from Upstate, Santa Cruz Biotechnology, Calbiochem, GeneTex, Inc., and
Sigma, respectively.
GST-Rad9 fusion proteins. The expression vector for the GST-fused chicken Rad9 fragment
containing the ATM phosphorylation site (Supplementary Fig. 3) was constructed as follows. A
chicken RAD9 DNA fragment was amplified by PCR using chicken RAD9 cDNA (Kobayashi et al.,
2004). The PCR fragment was treated with BamHI and XhoI, and the fragment was ligated into
BamHI- and XhoI-treated pGEX4T-3 (Pharmacia Biotech), yielding a GST-Rad9 fusion protein
expression plasmid. The GST-Rad9 fusion protein was purified with Glutathione Sepharose 4B
(Pharmacia Biotech).
Immunoblot analysis. Cells were harvested, washed, and lysed in lysis buffer A (50 mM Tris-
HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM
PMSF, 1 mM Na3VO4, 1 mM NaF, 1 mg/ml aprotinin, 1 mg/ml leupeptin). After centrifugation at
16,000 x g for 15 min, the protein concentrations of the cleared lysates were determined by the Bio-
Rad protein quantification assay. The same amounts of protein were separated by SDS-PAGE (8 or
15%), followed by blotting to nitrocellulose or to a Hybond-P (Amersham Biosciences) membrane.
Immunoprecipitation (IP) kinase assay for ATM. Cells were treated with IR, MNNG, or 15d-
PGJ2 in a CO2 incubator, then collected, washed with ice-cold PBS, and lysed in NETN150 (20 mM
Tris-HCl (pH 8.0), 1 mM EDTA, 150 mM NaCl, 0.5% NP-40, 1 mM PMSF, 10 mM
b–glycerophosphate, 1 mM NaF, 0.1 mM Na3VO4, 0.2 U/ml aprotinin, 10 mg/ml leupeptin, 5 mg/ml
pepstatin). After clarifying the cell lysates by centrifugation, antibodies to chicken ATM were added to
the extracts, and the reaction mixtures were rotated for 1 h at 4˚C, followed by incubation with protein
G-Sepharose 4 Fast Flow (Amersham Biosciences) for 1 h at 4˚C. The immunoprecipitates were
washed twice with lysis buffer and twice with kinase buffer (20 mM HEPES/KOH pH 7.5, 10 mM
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MgCl2, 10 mM MnCl2). The immunoprecipitates thus prepared was not contaminated with chromatin
components, as we could not detect Histone H3 in the immunoprecipates by immunoblot analysis
(data not shown). After centrifugation, the immunoprecipitates were resuspended in 20 ml of kinase
buffer containing 25 mM ATP, 1 mg GST-Rad9-fusion proteins, and 10 mCi of [g-32P]ATP. The reaction
mixtures were incubated for 30 min at 30 ˚C, then boiled in SDS sample buffer for SDS-PAGE (13%).
Gels were dried onto a filter paper and analyzed by autoradiography. Radioactivity was quantified with
a Bio-image Analyzer BAS1000 (Fujix). In other experiments, immunoprecipitated ATM, prepared as
described above, was mixed with 10 ml of MNNG or 15d-PGJ2 diluted in kinase buffer and 10 ml of
kinase buffer containing 50 mM ATP, 1 mg GST-Rad9 protein, and 10 mCi [g-32P]ATP. The reaction
mixtures were incubated for 30 min at 30˚C, and the ATM kinase activity was measured as described
above. For NEM treatment, immunoprecipitated ATM was resuspended in kinase buffer containing
NEM and incubated for 15 min at 25˚C. The immunoprecipitates were washed once with kinase buffer,
then used for the kinase assay.
Covalent binding of 15d-PGJ2 to ATM. We isolated several partial and overlapping human ATM
cDNA clones by library screening and PCR based on the published human ATM cDNA sequence
(Savitsky et al., 1995), and a full-length ATM cDNA was constructed from these cDNA clones. The
full-length human ATM cDNA expression vector with an HA-tag (HA-hATM) was prepared stepwise
by constructing an HA-tagged eukaryotic expression vector, pEF-3HA, and then cloning the entire
ATM coding sequence in the correct orientation into the expression vector, pEF-HA-hATM (the HA-
tag sequence is located upstream of the ATM coding sequence). To prepare ATM-/- DT40 cells stably
expressing a doxycycline-inducible HA-hATM gene (ATM-/-/HA-hATM), we used pUHD10-1 and
pUHD172-1neo plasmids (kindly provided by Dr. M. Gossen) (Gossen et al., 1995). ATM-/- DT40 cells
were transfected with both the PvuI-digested pUHD10-3-HA-hATM and XhoI-digested pUHD172-
1neo and selected with neomycin, yielding ATM-/-/HA-hATM DT40 cells.
ATM-/-/HA-hATM cells were incubated with doxycycline (1 mg/ml) overnight, collected, washed
with ice-cold PBS, and lysed in lysis buffer B (50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.5%
Tween20, 0.2% NP-40, 1 mM PMSF, 0.2 U/ml aprotinin, 10 mg/ml leupeptin, 5 mg/ml pepstatin). After
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clarifying the lysates by centrifugation, the extracts were reacted with an anti-HA antibody
(Boehringer Mannheim) for 2 h at 4˚C. The reaction mixtures were then incubated with protein G-
Sepharose 4 Fast Flow for 1 h at 4˚C. The immunoprecipitates were washed four times with lysis
buffer B, and twice with reaction buffer (20 mM HEPES/KOH, pH 7.5). The immunoprecipitates were
resuspended in 60 ml reaction buffer with or without 50 mM biotinylated 15d-PGJ2, incubated for 1 h
at 30˚C, then boiled in SDS sample buffer. The reaction products were separated by SDS-PAGE (6%)
and biotinylated proteins were detected with HRP-conjugated NeutrAvidin (Pierce Biotechnology).
For chicken ATM, anti-sera to chicken ATM and NETN150 supplemented with protease inhibitors
were used instead of the anti-HA antibodies and lysis buffer B, respectively.
ATM-/-/HA-hATM cells were incubated with doxycycline overnight, then incubated with or
without 20 mM biotinylated 15d-PGJ2 for 1 h in a CO2 incubator. The cells were collected, washed
with ice-cold PBS, and lysed in NETN150 supplemented with protease inhibitors. After centrifugation,
the cleared extracts were incubated with 50 ml NeutrAvidin-Plus beads (PIERCE Biotechnology) for 3
h at 4˚C with rotation and shaking. After centrifugation, the supernatants were collected as the
“Unbound” fractions. The beads were washed four times with the lysis buffer, and were boiled in SDS
sample buffer to prepare the bound proteins (“Bound”). The “Unbound” and “Bound” proteins were
separated by SDS-PAGE (6%), and HA-hATM was detected by using the anti-HA antibody as the
primary antibody.
Assessment of apoptosis. YZ5 and EBS cells were untreated or treated with 40 mM of 15d-PGJ2. After
a 24-h incubation, the cells were trypsinized and harvested. Apoptotic cells were stained with annexin
V using the Annexin V apoptosis kit (Clontech), and the annexin V–positive cells were detected by a
FACS Calibur (Becton Dickinson), following the manufacturer’s instructions.
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Figure legends
Fig. 1. MNNG activates the ATM kinase in an Nbs1- and Msh6-independent manner. (A)
Wild-type DT40 cells were treated with the indicated concentrations of MNNG for 1 h and the ATM
kinase activity was measured. “C” indicates the control treated with DMSO, the MNNG solvent. (B)
Wild-type (WT) and NBS1-/-/- DT40 cells were treated with 200 mM of MNNG for the indicated times,
and the cell extracts were subjected to immunoblot analysis with anti-phospho-Chk1 (Ser-345) (upper
panel), anti-phospho-Chk2 (Thr-68) (middle panel), and anti-Chk1 (lower panel) antibodies. (C)
NBS1-/-/- DT40 cells were treated with the indicated concentrations of MNNG for 1 h. Cell extracts
were prepared for the ATM kinase assay. (D) Wild-type and MSH6-/- DT40 cells were treated with 200
mM of MNNG for the indicated times, and cell extracts were subjected to immunoblot analysis with
anti-phospho-Chk1 (Ser-345) (upper panel), anti-phospho-Chk2 (Thr-68) (middle panel), and anti-
Chk1 (lower panel) antibodies. (E) MSH6-/- DT40 cells were treated with the indicated concentrations
21
of MNNG for 1 h, and the ATM kinase activity was measured.
Fig. 2. ATM is directly activated by MNNG through the modification of free SH groups. (A)
Immunoprecipitated ATM prepared from untreated wild-type DT40 cells with anti-chicken ATM
antibodies was mixed with 10 ml of various concentrations of MNNG and 10 ml of kinase buffer
containing 50 mM ATP, 1 mg GST-Rad9-fragment, and 10 mCi of [g-32P]ATP. The mixtures were
incubated for 30 min at 30˚C. The reaction products were subjected to SDS-PAGE followed by
autoradiography. (B) Immunoprecipitated ATM was resuspended in kinase buffer containing the
indicated concentrations of NEM and incubated for 15 min at 25˚C. The immunoprecipitated ATM
was then washed once with kinase buffer, and subjected to MNNG treatment (0.5 mM) followed by the
ATM kinase assay.
Fig. 3. ATM kinase activation by 15d-PGJ2. (A) Wild-type DT40 cells were treated with the
indicated concentrations of 15d-PGJ2 for 1 h. The cells were harvested for the IP ATM kinase assay.
“IB” indicates the relative amount of ATM in each extract. (B) Wild-type DT40 cells were untreated
(C) or treated with methyl acetate (MA, the 15d-PGJ2 solvent), 20 mM 15d-PGJ2 (P), or 20 mM 9,10-
dihydro-15d-PGJ2 (CAY) for 1 h. The treated cells were then used for the IP ATM kinase assay. (C)
Immunoprecipitated ATM prepared from untreated wild-type DT40 cells with anti-chicken ATM
antibodies was subjected to 15d-PGJ2 treatment, followed by the ATM kinase assay.
Fig. 4. Direct binding of 15d-PGJ2 to ATM. (A) Immunoprecipitated chicken ATM prepared
from wild-type (WT) and ATM-/- DT40 cells with anti-chicken ATM antibodies was incubated with or
without 50 mM biotinylated 15d-PGJ2. After incubation for 1 h at 30˚C, the immunoprecipitates were
washed thoroughly, and immunoblotted with HRP-conjugated NeutrAvidin. (B) ATM-/-/HA-hATM
DT40 cells were incubated with or without doxycycline (Dox) overnight, and immunoprecipitated
HA-tagged human ATM (HA-hATM) was prepared with anti-HA antibodies. The immunoprecipitates
were then treated with biotinylated 15d-PGJ2, and immunoblotted with HRP-conjugated NeutrAvidin.
(C) ATM-/-/HA-hATM DT40 cells were incubated with doxycycline overnight and incubated with or
without 20 mM biotinylated 15d-PGJ2 for 1 h. The cell extracts were then incubated with NeutrAvidin
Plus for 3 h at 4˚C. The NeutrAvidin- “Bound” and “Unbound” fractions were used for immunoblot
analysis with anti-HA antibodies.
Fig. 5. 15d-PGJ2 induces p53 phosphorylation and apoptosis in an ATM-dependent manner.
(A) EBS (ATM-deficient) and YZ5 (hATM-complemented) cells were treated with the indicated
concentrations of 15d-PGJ2 or 100 mM MNNG (M) for 1 h. Cell extracts were immunoblotted with
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anti-phospho-Chk2 (Thr-68) (upper panel), anti-phospho-p53 (Ser-15) (middle panel), and anti-actin
(lower panel) antibodies. (B) YZ5 and EBS cells were untreated (C), treated with 50 mM MNNG (M),
or exposed to 15 Gy IR (IR). After a 1-h incubation, cell extracts were prepared and used for
immunoblot analysis. (C) MCF7 cells were untreated (C) or treated with the indicated concentrations
of 15d-PGJ2 or MNNG for 4 h. Cell extracts were immunoblotted with anti-phospho-p53 (Ser-15),
anti-p53, anti-phospho-ATM (Ser-1981), anti-ATM, anti-phospho-H2AX (Ser-139), and anti-actin
antibodies. (D) YZ5 and EBS cells were untreated (open bar) or treated with 40 mM 15d-PGJ2 (closed
bar). After a 24-h incubation, the cells were trypsinized and harvested. Apoptotic cells were quantified
by annexin V FACS analysis. Each value represents the mean + SD for at least three experiments.
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